Damon DeSantis - Jun 20, 2022 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Damon DeSantis
Stock symbol
INBP
Transactions as of
Jun 20, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 05:33 PM
Previous filing
Feb 22, 2023
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50K $0.00 50K Jun 20, 2022 Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date.
F2 The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.